newsfilter
← Latest News
Business Wire·

Epizyme to Participate in Jefferies Virtual Healthcare Conference

Epizyme, (NASDAQ:EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that Robert Bazemore, President and Chief Executive Officer, will participate in a fireside chat